ASCOT PLC
27 September 1999
Date: 27 September 1999
Contacts: Howard Dyer, Executive Chairman
Ascot Plc 0171 815 0805
David Bick
Holborn Public Relations 0171 929 5599
david_bick@holbornpr.co.uk
ASCOT Plc
The Board of Ascot Plc has noted yesterday's press reports regarding the
possible acquisition of the 70% of ChiroTech Technology Limited from Celltech
Chiroscience plc that Ascot does not already own.
The Board confirms that Ascot continues to have a put or call option following
a standstill of the existing shareholder agreement between Ascot and
Chiroscience and that discussions are continuing between the parties regarding
this matter.
A further announcement will be made when appropriate.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.